These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 22465202)

  • 1. Adeno-associated virus (AAV) gene therapy for neurological disease.
    Weinberg MS; Samulski RJ; McCown TJ
    Neuropharmacology; 2013 Jun; 69():82-8. PubMed ID: 22465202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated viral vectors in the nervous system.
    Burger C; Nash K; Mandel RJ
    Hum Gene Ther; 2005 Jul; 16(7):781-91. PubMed ID: 16000060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson's disease treatment.
    Lee MH; Kang S; Um KH; Lee SW; Hwang H; Baek K; Choi JW
    J Transl Med; 2024 Jan; 22(1):53. PubMed ID: 38218903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-based in vivo gene therapy for neurological disorders.
    Ling Q; Herstine JA; Bradbury A; Gray SJ
    Nat Rev Drug Discov; 2023 Oct; 22(10):789-806. PubMed ID: 37658167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection.
    Huang L; Wan J; Wu Y; Tian Y; Yao Y; Yao S; Ji X; Wang S; Su Z; Xu H
    Life Sci; 2021 Apr; 270():119142. PubMed ID: 33524419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications.
    Ye D; Chukwu C; Yang Y; Hu Z; Chen H
    Adv Drug Deliv Rev; 2024 Aug; 211():115363. PubMed ID: 38906479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-Associated Virus (AAV) Vectors in the CNS.
    McCown TJ
    Curr Gene Ther; 2011 Jun; 11(3):181-8. PubMed ID: 21453285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells.
    Wang C
    J Neurovirol; 2008 Nov; 14(6):563-8. PubMed ID: 18991069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus (AAV) vectors in the CNS.
    McCown TJ
    Curr Gene Ther; 2005 Jun; 5(3):333-8. PubMed ID: 15975010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes.
    McClements ME; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):611-623. PubMed ID: 29259525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
    Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
    J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors.
    Vassalli G; Büeler H; Dudler J; von Segesser LK; Kappenberger L
    Int J Cardiol; 2003 Aug; 90(2-3):229-38. PubMed ID: 12957756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting.
    Chtarto A; Bockstael O; Tshibangu T; Dewitte O; Levivier M; Tenenbaum L
    Br J Clin Pharmacol; 2013 Aug; 76(2):217-32. PubMed ID: 23331189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
    Chamberlain K; Riyad JM; Weber T
    Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing transduction of the liver by adeno-associated viral vectors.
    Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
    Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
    Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
    Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.